Our mission is to provide accessible outsourcing opportunities without sacrificing quality.
USA FDA 503A compounding facility with formulation and end-to-end clinical trial solutions toward commercialization.
​
Whether your project is an academic research or IP still in research, we’re committed to assisting and supporting your project with the right outcome.
Optimized & Dedicated access
Now offering formulation, testing, and dispensing capabilities
Investigational Drug Service
​Pharmacists Play Key Role In Clinical Research
​Universal Compounding Pharmacy: A compounding pharmacy for Decentralized Clinical Trial Solutions
​
Universal Compounding Pharmacy (UCRx) has established a proven track record in providing innovative solutions for decentralized clinical trials. The pharmacy offers comprehensive support to researchers through an array of specialized services, including sourcing investigational drugs and raw materials, custom compounding of dosage forms, as well as advanced packaging and dispensing solutions. UCRx’s state-of-the-art primary and secondary engineering controls enable the formulation of a wide range of pharmaceutical products, ensuring the flexibility required for investigational drug development.
​
The facility currently supports numerous clinical trials at both local and national levels and has cultivated strong collaborative relationships with renowned academic and research institutions. UCRx’s capabilities and infrastructure position it as a vital partner in advancing decentralized clinical trial methodologies and improving patient access to experimental therapies.
Every trial begins with a pharmacy consultant
Clinical Trial Drug Sourcing
Testing & Validation
Service
Outcomes
Access to big 3 national distributors for brand and generics.
Access to big 3 national distributors for Active Pharmaceutical Ingredients (APIs)
Onsite formulatio and compound all dosage forms when not available.
Lean Six-Sigma methodology applied to each production
Collaborate with FDA registered, DEA registered, and ISO 17025:2005 accredited for GMP and nonGMP testings
Method Development and Validation
Method Suitability Test
Sterility Method Suitability
Stability-Indicating Assay Study program.
USP compliant batch release testing programs
​
Pharmacist 24/7 On-Call
Emergency unblinding access
Telepharmacy patient consultation
Direct dispensing to patient or investigators
​IP Return & reconcilcation
IP Destruction Service
Protocol Management & Randomization control.
​Each clinical trial is driven by an in-house project manager.
​Shipping and Dispensing with traceability.
Clinical Trial Drug Sourcing leverages USA Big 3 Drug distribution relationships to source drugs or APIs
Exceptional Access
broad access to the drugs a trial needs, anywhere in the USA
​continuous supply throughout the course of a trial
competitive pricing through drug wholesaling contracting
track-and-trace compliant
**The Role of Certified Research Pharmacists at UCRx in Clinical Trials**
Certified research pharmacists at UCRx play a crucial, though often behind-the-scenes, role in the facilitation of clinical trials. Our pharmacists are responsible for the design and compounding of blinded drugs, tailored to meet the specific needs of both simple and complex trials. Their expertise ensures the integrity of investigational drug formulations, while maintaining the blinding required for unbiased research outcomes. By supporting clinical research in this way, UCRx pharmacists contribute significantly to the advancement of clinical trials and the development of new therapies.
Investigational Drug program at Universal Compounding Pharmacy
*Decentralized Clinical Trials: New Therapies or Repurposing Existing Drugs*
Henry Truong, PharmD, MS, serves as the director of investigational drugs at Mariner Advanced Pharmacy in Redwood City and Universal Compounding Pharmacy in Signal Hill, CA. Since founding these pharmacies in 2011 & 2019, Dr. Truong has played a pivotal role as a compounding pharmacist and later launched the Investigational Drug Service (IDS) division.
​
Dr. Truong’s journey toward becoming a research pharmacist unfolded gradually. His earlier clinical roles exposed him to investigational drugs service and allowed him to collaborate with local academic researchers while serving community patients. Currently, he supports clinical trials across prominent academic institutions and pharmaceutical companies.
>> click here to find some sample trial projects.
​
He has contributed to numerous phase 1 and 2 trials with elite researchers. One notable trial involves investigating a novel drug, jacifusen, for treating rare ALS in patients with the FUS gene, administered directly into the intrathecal space.
​
Phase 1 clinical trials, also known as early-phase trials, represent the first time an experimental drug or treatment is tested on human subjects. These trials focus on evaluating safety, side effects, optimal dosages, and the best method of administration, such as oral, intravenous, or injection, while monitoring the treatment's effects on the body.
"The rare ALS study excites me because it offers patients a potential last-resort treatment option," says Dr. Truong.
​
He and his team take pride in their involvement from the early stages of trials, from writing protocols and activating studies to dispensing medication and publishing results. "It’s incredibly satisfying to know that our work could lead to new treatment options for patients with limited or no alternatives," he adds.
